Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 12
Journal homepage
44
Views
9
CrossRef citations to date
0
Altmetric
Review

Molecular monitoring for rejection and graft outcome in kidney transplantation

Michael Eikmans Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Building 1, Albinusdreef 2, 2333 ZA Leiden, The Netherlands +31 7152 66722; +31 7152 65267; [email protected]
, PhD,
Dave L Roelen Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Building 1, Albinusdreef 2, 2333 ZA Leiden, The Netherlands +31 7152 66722; +31 7152 65267; [email protected]
&
Frans HJ Claas Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Building 1, Albinusdreef 2, 2333 ZA Leiden, The Netherlands +31 7152 66722; +31 7152 65267; [email protected]
Pages 1365-1379 | Published online: 25 Nov 2008

Bibliography

  • Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-12
  • Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999;56:783-93
  • Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10:167-81
  • Hariharan S, Mc Bride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002;62:311-8
  • Nankivell BJ, Borrows RJ, Fung LS, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-33
  • Ferguson R. Acute rejection episodes – best predictor of long-term primary cadaveric renal-transplant survival. Clin Transplant 1994;8:328-31
  • Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal-allograft survival (T1/2). Transplantation 1994;57:857-9
  • Massy ZA, Guijarro C, Wiederkehr MR, et al. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 1996;49:518-24
  • Pascual M, Theruvath T, Kawai T, et al. Medical progress – Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-90
  • Sijpkens YWJ, Zwinderman AH, Mallat MJK, et al. Intercept and slope analysis of risk factors in chronic allograft nephropathy. Graft 2002;5:109-14
  • Van Saase JL, Van Der Woude FJ, Thorogood J, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995;59:1280-5
  • Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998;4:1392-6
  • Fischbein MP, Yun J, Laks H, et al. Role of CD8(+) lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 2002;123:803-9
  • Jose MD, Ikezumi Y, Van Rooijen N, et al. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003;76:1015-22
  • Russell PS, Chase CM, Sykes M, et al. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001;167:5731-40
  • Vongwiwatana A, Tasanarong A, Hidalgo LG, Halloran PF. The role of B cells and alloantibody in the host response to human organ allografts. Immunol Rev 2003;196:197-218
  • Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008;14:88-92
  • Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008;9:239-44
  • Peters JH, Hilbrands LB, Koenen HJ, Joosten I. Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy. PLoS One 2008;3:e2233
  • Alegre ML, Florquin S, Goldman M. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol 2007;19:563-8
  • Lajoie G, Nadasdy T, Laszik Z, et al. Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 1996;9:1118-25
  • Hongwei W, Nanra RS, Stein A, et al. Eosinophils in acute renal allograft rejection. Transpl Immunol 1994;2:41-6
  • Ishida T, Hyodo Y, Ishimura T, et al. Mast cell numbers and protease expression patterns in biopsy specimens following renal transplantation from living-related donors predict long-term graft function. Clin Transplant 2005;19:817-24
  • Kormendi F, Amend WJ Jr. The importance of eosinophil cells in kidney allograft rejection. Transplantation 1988;45:537-9
  • Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005;5:807-17
  • Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999;10:2208-14
  • Worthington JE, Mc Ewen A, Mc William LJ, et al. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 2007;83:398-403
  • Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-23
  • Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria – an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003;3:708-14
  • Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007;7:518-26
  • Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8:753-60
  • Rush DN, Henry SF, Jeffery JR, et al. Histological-findings in early routine biopsies of stable renal-allograft recipients. Transplantation 1994;57:208-11
  • Rush DN, Jeffery JR, Gough J. Sequential Protocol biopsies in renal-transplant patients – clinicopathological correlations using the Banff schema. Transplantation 1995;59:511-4
  • Scholten EM, Rowshani AT, Cremers S, et al. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol 2006;17:2622-32
  • Mengel M, Gwinner W, Schwarz A, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007;7:356-65
  • Furness PN, Philpott CM, Chorbadjian MT, et al. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 2003;76:969-73
  • Schwarz A, Gwinner W, Hiss M, et al. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 2005;5:1992-6
  • Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001;344:947-54
  • Aquino-Dias EC, Joelsons G, Da Silva DM, et al. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int 2008;73:877-84
  • Louis S, Braudeau C, Giral M, et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006;81:398-407
  • Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998;66:562-6
  • Veronese F, Rotman S, Smith RN, et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 2007;7:914-22
  • Geyer SJ. Urinalysis and urinary sediment in patients with renal disease. Clin Lab Med 1993;13:13-20
  • Chan RW, Szeto CC. Advances in the clinical laboratory assessment of urinary sediment. Clin Chim Acta 2004;340:67-78
  • Gwinner W. Renal transplant rejection markers. World J Urol 2007;25:445-55
  • Haber M, Ward P. Urine. In: McClatchey KD, editor, Clinical laboratory medicine. Philadelphia: Lippincott Williams and Wilkins; 2002; p. 519-51
  • Medeiros M, Sharma VK, Ding R, et al. Optimization of RNA yield, purity and mRNA copy number by treatment of urine cell pellets with RNAlater. J Immunol Methods 2003;279:135-42
  • Loong CC, Hsieh HG, Lui WY, et al. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002;197:322-32
  • Ding R, Li B, Muthukumar T, et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation 2003;75:1307-12
  • Muthukumar T, Ding R, Dadhania D, et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation 2003;75:1565-70
  • Tatapudi RR, Muthukumar T, Dadhania D, et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004;65:2390-7
  • Kotsch K, Mashreghi MF, Bold G, et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004;77:1866-75
  • Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005;353:2342-51
  • Mas VR, Maluf DG, Archer KJ, et al. Study of mRNA growth factors in urinary cells of kidney transplant recipients as predictors of chronic allograft nephropathy. Transplantation 2005;80:1686-91
  • Yannaraki M, Rebibou JM, Ducloux D, et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006;19:759-68
  • Matz M, Beyer J, Wunsch D, et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006;69:1683-90
  • Mas V, Maluf D, Archer K, et al. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation 2007;83:448-57
  • Seiler M, Brabcova I, Viklicky O, et al. Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant 2007;7:423-33
  • Renesto PG, Ponciano VC, Cenedeze MA, et al. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 2007;7:1661-5
  • Mas VR, Mas LA, Archer KJ, et al. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24
  • Schaub S, Mayr M, Honger G, et al. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation 2007;84:104-12
  • Grimm PC, Mc Kenna R, Nickerson P, et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999;10:1582-9
  • Lipman ML, Shen Y, Jeffery JR, et al. Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection. Transplantation 1998;66:1673-81
  • Rowshani AT, Florquin S, Bemelman F, et al. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection. Kidney Int 2004;66:1417-22
  • Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005;5:573-81
  • Bestard O, Cruzado JM, Rama I, et al. Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008;19(10):2020-6
  • Sayegh MH. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1999;56:1967-79
  • Von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-34
  • Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004;4:1475-89
  • Shoker A, George D, Yang H, Baltzan M. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. Transplantation 2000;70:497-505
  • Dugre FJ, Gaudreau S, Belles-Isles M, et al. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection. Transplantation 2000;70:1074-80
  • Sabek O, Dorak MT, Kotb M, et al. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002;74:701-7
  • Simon T, Opelz G, Wiesel M, et al. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003;3:1121-7
  • Simon T, Opelz G, Wiesel M, et al. Serial peripheral blood interleukin-18 and perforin gene expression measurements for prediction of acute kidney graft rejection. Transplantation 2004;77:1589-95
  • Gibbs PJ, Tan LC, Sadek SA, Howell WM. Quantitative detection of changes in cytokine gene expression in peripheral blood mononuclear cells correlates with and precedes acute rejection in renal transplant recipients. Transpl Immunol 2005;14:99-108
  • Dalton RS, Webber JN, Pead P, et al. Immunomonitoring of renal transplant recipients in the early posttransplant period by sequential analysis of chemokine and chemokine receptor gene expression in peripheral blood mononuclear cells. Transplant Proc 2005;37:747-51
  • Veale JL, Liang LW, Zhang Q, et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 2006;67:777-86
  • Alakulppi NS, Kyllonen LE, Partanen J, et al. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation 2007;83:791-8
  • Petrie JJB, Rigby RJ, Hawley CM, et al. Effect of Okt3 in steroid-resistant renal-transplant rejection. Transplantation 1995;59:347-52
  • Madden RL, Mulhern JG, Benedetto BJ, et al. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transpl Int 2000;13:344-50
  • Gulanikar AC, Macdonald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of 1st cadaver kidney-transplants. Transplantation 1992;53:323-8
  • Tesi RJ, Henry ML, Elkhammas EA, Ferguson RM. Predictors of long-term primary cadaveric renal-transplant survival. Clin Transplant 1993;7:345-52
  • Vereerstraeten P, Abramowicz D, De Pauw L, Kinnaert P. Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery. Transplantation 1997;63:1739-43
  • Nickeleit V, Vamvakas EC, Pascual M, et al. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998;9:1301-8
  • Haas M, Kraus ES, Samaniego-Picota M, et al. Acute renal allograft rejection with intimal arteritis: histologic predictors of response to therapy and graft survival. Kidney Int 2002;61:1516-26
  • Ozdemir BH, Demirhan B, Ozdemir FN, et al. The role of microvascular injury on steroid and OKT3 response in renal allograft rejection. Transplantation 2004;78:734-40
  • Regele H, Exner M, Watschinger B, et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001;16:2058-66
  • Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002;13:242-51
  • Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002;13:234-41
  • Lorenz M, Regele H, Schillinger M, et al. Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Transplantation 2004;78:447-52
  • Vargha R, Mueller T, Arbeiter K, et al. C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejection. Pediatr Transplant 2006;10:449-53
  • Magil AB, Tinckam KJ. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant 2006;21:1382-8
  • Kayler LK, Kiss L, Sharma V, et al. Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. Transplantation 2008;85:813-20
  • Bishop GA, Hall BM, Duggin GG, et al. Immunopathology of renal-allograft rejection analyzed with monoclonal-antibodies to mononuclear cell markers. Kidney Int 1986;29:708-17
  • Sarwal MM, Jani A, Chang S, et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 2001;62:21-31
  • Mengel M, Mueller I, Behrend M, et al. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection. Transpl Int 2004;17:293-300
  • Desvaux D, Schwarzinger M, Pastural M, et al. Molecular diagnosis of renal-allograft rejection: Correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 2004;78:647-53
  • Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003;349:125-38
  • Hippen BE, DeMattos A, Cook WJ, et al. Association of CD20+infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005;5:2248-52
  • Eikmans M, Roos-Van Groningen MC, Sijpkens YWJ, et al. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: Investigation of the prognostic value. J Am Soc Nephrol 2005;16:3771-86
  • Doria C, Di FF, Ramirez CB, et al. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Transplant Proc 2006;38:3441-4
  • Kayler LK, Lakkis FG, Morgan C, et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007;7:949-54
  • Charney DA, Nadasdy T, Lo AW, Racusen LC. Plasma cell-rich acute renal allograft rejection. Transplantation 1999;68:791-7
  • Desvaux D, Le Gouvello S, Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004;19:933-9
  • Gartner V, Eigentler TK, Viebahn R. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation 2006;81:986-91
  • Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003;63:1888-93
  • Matheson PJ, Dittmer ID, Beaumont BW, et al. The macrophage is the predominant inflammatory cell in renal allograft intimal arteritis. Transplantation 2005;79:1658-62
  • Vergara E, Gomez-Morales M, Osuna A, et al. Immunohistochemical quantification of leukocyte subsets in the long-term prognosis of kidney transplants. Transplant Proc 1998;30:2380-3
  • Alexopoulos E, Leontsini M, Papadimitriou M. Macrophages and HLA-DR (+) cells in acutely rejecting kidney transplants, predict subsequent graft survival, even after reversal of the acute episode. Nephrology 1998;4:113-7
  • Ozdemir BH, Demirhan B, Gungen Y. The presence and prognostic importance of glomerular macrophage infiltration in renal allografts. Nephron 2002;90:442-6
  • Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005;68:1866-74
  • Ramos EL, Barri YM, Croker BP, et al. Thromboxane synthase expression in renal transplant patients with rejection. Transplantation 1995;59:490-4
  • Ozdemir BH, Bilezikci B, Haberal AN, et al. Histologic evaluation, HLA-DR expression, and macrophage density of renal biopsies in OKT3-treated acute rejection: Comparison with steroid response in acute rejection. Transplant Proc 2000;32:528-31
  • Mansour H, Homs S, Desvaux D, et al. Intragraft levels of Foxp3 mrna predict progression in renal transplants with borderline change. J Am Soc Nephrol 2008
  • Martin L, Funes DLV, Bocrie O, et al. Detection of Foxp3+ cells on biopsies of kidney transplants with early acute rejection. Transplant Proc 2007;39:2586-8
  • Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001;344:655-64
  • Game DS, Lechler RI. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 2002;10:101-8
  • Valujskikh A, Lakkis FG. In remembrance of things past: memory T cells and transplant rejection. Immunol Rev 2003;196:65-74
  • Lakkis FG. Transplantation tolerance: a journey from ignorance to memory. Nephrol Dial Transplant 2003;18:1979-82
  • Najafian N, Albin MJ, Newell KA. How can we measure immunologic tolerance in humans? J Am Soc Nephrol 2006;17:2652-63
  • Salama AD, Womer KL, Sayegh MH. Clinical transplantation tolerance: many rivers to cross. J Immunol 2007;178:5419-23
  • Hoffmann SC, Pearl JP, Blair PJ, Kirk AD. Immune profiling: molecular monitoring in renal transplantation. Front Biosci 2003;8:e444-62
  • Susal C, Pelzl S, Simon T, Opelz G. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc 2004;36:29-34
  • Iacomini J, Sayegh MH. Measuring T cell alloreactivity to predict kidney transplant outcomes: are we there yet? J Am Soc Nephrol 2006;17:328-30
  • Ashton-Chess J, Giral M, Soulillou JP, Brouard S. Can immune monitoring help to minimize immunosuppression in kidney transplantation? Transpl Int 2008
  • Li Y, Koshiba T, Yoshizawa A, et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004;4:2118-25
  • Brouard S, Dupont A, Giral M, et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 2005;5:330-40
  • Alvarez CM, Opelz G, Giraldo MC, et al. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant 2005;5:746-56
  • Roussey G, Giral M, Moreau A, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006;6:736-46
  • Baeten D, Louis S, Braud C, et al. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2006;17:294-304
  • Martinez-Llordella M, Puig-Pey I, Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007;7:309-19
  • Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007;104:15448-53
  • Braud C, Baeten D, Giral M, et al. Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem 2008;103:1681-92
  • Sivozhelezov V, Braud C, Giacomelli L, et al. Immunosuppressive drug-free operational immune tolerance in human kidney transplants recipients. Part II. Non-statistical gene microarray analysis. J Cell Biochem 2008;103:1693-706
  • Braudeau C, Ashton-Chess J, Giral M, et al. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 2008;86:130-6
  • Dadhania D, Muthukumar T, Ding R, et al. Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation 2003;75:1752-4
  • Ashton-Chess J, Giral M, Mengel M, et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008;19:1116-27
  • Molne J, Nyberg G, Blohme I, et al. Glomerular C3c deposition and intravascular macrophage accumulation in early humoral renal allograft rejection signifies a poor short-term outcome. APMIS 2006;114:700-11
  • Kuypers DR, Lerut E, Evenepoel P, et al. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003;76:102-8
  • Eikmans M, Sijpkens YW, Baelde HJ, et al. High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 2002;73:573-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.